Evaluation of CA19-9 as a tumor marker in urothelial malignancy.

@article{Chuang2004EvaluationOC,
  title={Evaluation of CA19-9 as a tumor marker in urothelial malignancy.},
  author={Cheng-Keng Chuang and S I A Liao},
  journal={Scandinavian journal of urology and nephrology},
  year={2004},
  volume={38 5},
  pages={359-65}
}
OBJECTIVE Carbohydrate antigen 19-9 (CA19-9) is known to be a marker with a high positive rate in pancreatic cancer. There are limited data on the use of CA19-9 as a tumor marker in bladder carcinoma. We tested the expression of CA19-9 in transitional cell carcinoma (TCC) cell lines and bladder cancer patients to determine its usefulness in clinical applications. MATERIAL AND METHODS The expression of CA19-9 was determined in six TCC cell lines and 42 bladder carcinoma tissues using two… CONTINUE READING